Return to search results.
Complete title: A Phase II Study of Weekly Maintenance Bortezomib and Rituximab in Mantle Cell Lymphoma S/P Autologous Hematopoietic Cell Transplantation
|Research Study Number||2620.00|
|Principal Investigator||Leona Holmberg, MD, PhD|
Research Study Description
PURPOSE: This phase II trial is studying how well giving bortezomib and rituximab together works in treating patients with mantle cell lymphoma who have previously undergone stem cell transplantation
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Lymphoma; Lymphoproliferative Disorders; Lymphoma, Non-Hodgkin (NHL)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.